कोशिश गोल्ड - मुक्त
PhnyX Lab secures $4 M to transform life sciences sector
BioSpectrum Asia
|BioSpectrum Asia Sep 2025
PhnyX Lab, a pioneering GenAI startup from South Korea transforming how life science companies operate, has announced the successful closing of a $4 million seed round through a Simple Agreement for Future Equity (SAFE). The round was led by SK Networks, with participation from several prominent angel investors—including Aidan Gomez, co-founder and CEO of Cohere, and Illia Polos-ukhin, co-founder of NEAR Protocol—both of whom are original co-authors of "Attention Is All You Need," the paradigm-shifting work that ushered in the transformer era and laid the foundation for today's generative AI models, including ChatGPT.
-

Their involvement follows extensive discussions with both Sung-hwan Choi, Executive Advisor to PhnyX Lab and COO of SK Networks, and Min-seok Bae, CEO of PhnyX
यह कहानी BioSpectrum Asia के BioSpectrum Asia Sep 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
BioSpectrum Asia से और कहानियाँ
BioSpectrum Asia
First Pacific woman to serve as public health director in NZ
The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Hugel launches botulinum toxin Letybo in Malaysia
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Australia designs smart wound monitor to improve chronic infection care
Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Revvity unveils innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B
Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education
HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI
Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jeong Eun Kyeong steps in as Minister of Health and Welfare, South Korea
Jeong Eun Kyeong, a South Korean infectious disease and public health expert, has been appointed to serve as the Minister of Health and Welfare.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
India builds nanosensor to detect deadly infections in minutes
A team of scientists at the National Institute of Technology (NIT) Calicut in India has developed a new highly sensitive, low-cost, point-of-care device with an electrochemical biosensor that could help early diagnosis of sepsis at the bedside of the patient.
1 min
BioSpectrum Asia Sep 2025
Listen
Translate
Change font size